Evidence map›Paper›PMID 40489769›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2025

Cutting edge: Extrinsic and intrinsic sex effects differentially regulate pulmonary ILC2 numbers, phenotype, and function.

Abigael P Williams, Sean Turner, Magdalena Chlebicz, Hannah Carter, Reegan A J Miller, Bujana Allushi, Mandi M Roe, Laura Loriel Mejia, Jocelyn Labombarde, José Alberola-Ila and 1 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abigael P WilliamsArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.ORCID 0009-0005-6667-4053
Sean TurnerArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.ORCID 0000-0001-9879-0183
Magdalena ChlebiczArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.ORCID 0000-0001-7504-0929
Hannah CarterArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Reegan A J MillerArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.ORCID 0009-0004-5374-3171
Bujana AllushiArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Mandi M RoeArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Laura Loriel MejiaArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Jocelyn LabombardeArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
José Alberola-IlaArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Susan KovatsArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.ORCID 0000-0001-5479-9952

Funding

IRF4-Mediated Regulation of Lung Dendritic Cells During Viral InfectionR01HL119501 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KOVATS, SUSAN · 2014 to 2017
$1.7M
5-Laser Cytek Aurora Spectral Flow CytometerS10OD028479 · OD · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2020 to 2020
$317k
The Role of Lymphatic Endothelial Cell- Expressed Sphingosine-1-Phosphate Receptor 1 on Immune Cell Trafficking and Response to Influenza VirusF30HL176087 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Jocelyn Labombarde · 2024 to 2026
$140k
NHLBI NIH HHS F30 HL176087NHLBI NIH HHS R01 HL119501NIH HHS F30HL176087NIH HHS HL119501NIH HHS S10 OD028479NIH HHS S10OD028479-01Oklahoma Center for Adult Stem Cell Research 251001Oklahoma Medical Research FoundationPresbyterian Health Foundation
6 · The paper itself

Abstract

Pulmonary type 2 innate lymphocytes (ILC2s) show sex dimorphism in numbers, phenotype, and function. We used a novel strategy of competitive, mixed male-female donor bone marrow chimeras to determine if sex differences in murine ILC2s result from extrinsic factors in the recipient environment or from durable intrinsic variables in donor cells. We show that the recipient sex environment regulated ILC2 numbers and IL33R/ST2 and KLRG1 surface levels, independent of donor sex. In contrast, ILC2 production of interleukin (IL)-5 depended on donor cell sex and the type of inflammatory stimulus. After allergen exposure, or upon treatment of naïve lung cells with PMA/ionomycin, a higher frequency of female donor-derived ILC2s produced IL-5. In contrast, influenza virus infection induced a greater proportion of male donor-derived ILC2s to produce IL-5. Thus, while a current sex environment governed pulmonary ILC2 numbers and canonical markers, ILC2 functional responses were shaped by durable factors stemming from intrinsic biological sex.

Indexed as

Immunity, InnateLungLymphocytesAnimalsFemaleInterleukin-5Lectins, C-TypeMaleMiceMice, Inbred C57BLOrthomyxoviridae InfectionsPhenotypeReceptors, ImmunologicSex CharacteristicsSex FactorsInterleukin-5Klrg1 protein, mouseLectins, C-TypeReceptors, Immunologicbone marrow chimerainnate lymphocyteslungrespiratory virussex differences

Identifiers

PMID40489769
PMCPMC12394977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.